Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Long-Term Deferred Tax (2020 - 2022)

IceCure Medical (ICCM) has disclosed Long-Term Deferred Tax for 3 consecutive years, with $17.3 million as the latest value for Q4 2022.

  • Quarterly Long-Term Deferred Tax rose 21.84% to $17.3 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $17.3 million through Dec 2022, up 21.84% year-over-year, with the annual reading at $17.3 million for FY2022, 21.84% up from the prior year.
  • Long-Term Deferred Tax for Q4 2022 was $17.3 million at IceCure Medical, up from $14.2 million in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $17.3 million in Q4 2022, with the low at $12.0 million in Q4 2020.
  • Average Long-Term Deferred Tax over 3 years is $14.5 million, with a median of $14.2 million recorded in 2021.
  • The sharpest move saw Long-Term Deferred Tax rose 17.94% in 2021, then grew 21.84% in 2022.
  • Over 3 years, Long-Term Deferred Tax stood at $12.0 million in 2020, then rose by 17.94% to $14.2 million in 2021, then rose by 21.84% to $17.3 million in 2022.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $17.3 million, $14.2 million, and $12.0 million for Q4 2022, Q4 2021, and Q4 2020 respectively.